NCT05757219 2026-03-31Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell TherapyH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Recruiting27 enrolled
NCT02917993 2026-02-09An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung CancerIncyte CorporationPhase 1/2 Completed59 enrolled